<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350249</id>
  <title nil="true"/>
  <common-name>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[4-oxo-2-[(e)-2-phenylethenyl]quinazolin-3-yl]benzenecarboximidamide</common-name>
  <description>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[4-oxo-2-[(e)-2-phenylethenyl]quinazolin-3-yl]benzenecarboximidamide is a chemical compound with the formula C30H23N7O2. With an average molecular weight of 513.50 g/mol, N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[4-oxo-2-[(e)-2-phenylethenyl]quinazolin-3-yl]benzenecarboximidamide is a heavy molecule.</description>
  <cas>127786-22-5</cas>
  <pubchem-id>9589329</pubchem-id>
  <chemical-formula>C30H23N7O2</chemical-formula>
  <weight>513.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:12:20Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:12:20Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C=CC2=NC3=CC=CC=C3C(=O)N2N=C(C4=CC=CC=C4)N=NC5=CC=C(C=C5)C(=O)NN</moldb-smiles>
  <moldb-formula>C30H23N7O2</moldb-formula>
  <moldb-inchi>InChI=1S/C30H23N7O2/c31-33-29(38)23-16-18-24(19-17-23)34-35-28(22-11-5-2-6-12-22)36-37-27(20-15-21-9-3-1-4-10-21)32-26-14-8-7-13-25(26)30(37)39/h1-20H,31H2,(H,33,38)/b20-15+,35-34?,36-28-</moldb-inchi>
  <moldb-inchikey>ZNNMQXHCHIYJLQ-CUJDYLPDSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.191323</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346142</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[4-oxo-2-[(e)-2-phenylethenyl]quinazolin-3-yl]benzenecarboximidamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300556</sync-id>
  <structure-inchikey>ZNNMQXHCHIYJLQ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>8000001000000000000000000000002000000000000000000000400000200000000000000020040000000000000000000000020000800050000080000000008000000000000000200000000002000000040040000000000000001100000010000000000200000000000011000000000000000000000002000000000000008040000008000000800010000001000000000000000200000000000000000000004400000848000000000000000000000000000000000010200000000401000000800000000000084000000044000000200002000000000020000000000000030000c0000000000400000000000000005000000000004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBkBoAAAAAwMBBkBoAAAA
AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGAGgAAAAD
AwEGAGgAAAADAwEGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEG
QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMECAAo
AAAAAwIHQCgAAAADAwcAKAAAAAMDBgAoAAAAAwQGQCgAAAADBAZAaAAAAAMD
AQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQcAKAAAAAMD
BwAoAAAAAwMGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBo
AAAAAwMBBkBoAAAAAwMBBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQcAYAAA
AAECCwABaAwBAmgMAgNoDAMEaAwEBWgMAwYgBgcoAgcIIAgJaAwJCmgMCgto
DAsMaAwMDWgMDQ5oDA4PaAwPEGgMEBEoAhASaAwSEyATFCgCFBUgFRZoDBYX
aAwXGGgMGBloDBkaaAwUGyAbHCgCHB0gHR5oDB4faAwfIGgMICFoDCEiaAwg
IyAjJCgCIyUgJSYABQBoDBIIaAwPCmgMGhVoDCIdaAxCBQAAAAYABQQDAgEG
CQoPEBIIBgsMDQ4PCgYWFxgZGhUGHh8gISIdFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:14Z</structure-indexed-at>
</compound>
